Loading
Latest filing published 19 Jul 2022 for Pure Bioscience, INC., €49k.
No signal scores available.
Only one filing by David Rendall is known so far (19 July 2022): a share grant, €49k, in Pure Bioscience, Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration